CLDN3 and ovarian carcinoma: Claudin-3 and claudin-4 are highly overexpressed in ovarian cancer including serous carcinoma compared to normal ovarian tissues, and their expression is also upregulated in several other malignancies, including breast, gastric, pancreatic, prostate and uterine cancers (Table 2).